Security key
05338F306
Avalo Therapeutics, Inc. - COMMON STOCK (AVTX)
CUSIP: 05338F306
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 8,255,057
- Total 13F value
- $66,123,710
- Share change
- +724,536
- SEC-reported price per share
- $8.01
- Number of holders
- 33
- Value change
- +$5,779,142
- Number of buys
- 15
- Number of sells
- 8
- Shares outstanding
- 53,624,847
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
33
Top holders
10
AVTX full security history
Ownership snapshot
Full 13F holder table
Avalo Therapeutics, Inc. SEC filings
Avalo Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of AVTX - Avalo Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
Lead comparable stake: 1.9%
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL leads the comparable SEC ownership view at 1.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Comparable ownership
Top 5
BVF INC/IL
1.9%
Ikarian Capital, LLC
1.8%
ORBIMED ADVISORS LLC
1.8%
RA CAPITAL MANAGEMENT, L.P.
1.8%
Deep Track Capital, LP
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
1.9%
|
$7,702,525
1,036,679 shares
|
— | 31 Dec 2024 |
| Ikarian Capital, LLC |
13F
Company
|
1.8%
|
$7,209,024
970,259 shares
|
— | 31 Dec 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
1.8%
|
$7,184,810
967,000 shares
|
— | 31 Dec 2024 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
1.8%
|
$7,184,810
967,000 shares
|
— | 31 Dec 2024 |
| Deep Track Capital, LP |
13F
Company
|
1.6%
|
$6,441,810
867,000 shares
|
— | 31 Dec 2024 |
| Affinity Asset Advisors, LLC |
13F
Company
|
1%
|
$4,092,184
550,765 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
33
Shares
8,255,057
Rows available
33
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
33
Q1 2025 holders
33
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|